Literature DB >> 4893148

Carbenicillin therapy of gram-negative bacilli infections.

G P Bodey, V Rodriguez, J K Luce.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4893148     DOI： 10.1097/00000441-196906000-00007

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  15 in total

Review 1.  Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients.

Authors:  Michael J Satlin; Thomas J Walsh
Journal:  Transpl Infect Dis       Date:  2017-10-25       Impact factor: 2.228

2.  Procedures for the assay of carbenicillin in body fluids.

Authors:  J Burnett; R Sutherland
Journal:  Appl Microbiol       Date:  1970-02

3.  Comparison and evaluation of carbenicillin disks in diffusion susceptibility testing.

Authors:  J M Matsen; M E Lund; D C Brooker
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

4.  Imipenem-cilastatin as initial therapy for febrile cancer patients.

Authors:  G P Bodey; M E Alvarez; P G Jones; K V Rolston; L Steelhammer; V Fainstein
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

5.  Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats.

Authors:  R E Scott; H G Robson
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

6.  Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.

Authors:  S C Schimpff; S Landesman; D M Hahn; H C Standiford; C L Fortner; V M Young; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

7.  In vitro studies of semisynthetic alpha-(substituted-ureido) penicillins.

Authors:  G P Bodey; D Stewart
Journal:  Appl Microbiol       Date:  1971-04

8.  Pirbenicillin: comparison with carbenicillin and BL-P1654, alone and with gentamicin, against Pseudomonas aeruginosa.

Authors:  C E Lopez; H C Standiford; B A Tatem; F M Calia; S C Schimpff; M J Snyder; R B Hornick
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

9.  Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients.

Authors:  J C Wade; S C Schimpff; K A Newman; C L Fortner; M R Moody; V M Young; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

10.  Mezlocillin for treatment of infections in cancer patients.

Authors:  B F Issell; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.